The client’s voice: why they consistently choose Kayentis
At Kayentis, client satisfaction isn’t just a goal—it’s our standard. We pride ourselves on delivering
Kayentis & RWS partnering for success
Kayentis (global provider of eCOA and DCT solutions) and RWS (language service provider (LSP) and linguistic validation experts) were selected to create and implement the electronic versions of the COAs (eCOAs) on a high priority study with a new client, pioneer in biotechnology.
The study is a Global Small Cell Lung Cancer Phase II Study, spanning 26 languages and 7 instruments, with 100 participating sites.
The long-standing partnership between Kayentis and RWS enabled a successful study start-up so that the final study materials were completed and delivered earlier than quoted timelines.
The collaborative efforts established between both partners helped mitigate any potential delays arising from external review requirements and changing priorities to ensure a successful study.
Learn more:
At Kayentis, client satisfaction isn’t just a goal—it’s our standard. We pride ourselves on delivering
At Kayentis, we value each individual and we form a community that goes beyond the
In this last episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
In this third episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
Integrating PROs into studies on MASH, also known as NASH, is crucial. MASH is a debilitating
Asthma clinical trials present several specificities, such as the use of disease-specific health-related quality of
Last update : 27 July 2022